These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 31274189)

  • 1. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
    Milligan R; Daher A; Graves PM
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
    Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
    Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.
    Galappaththy GN; Tharyan P; Kirubakaran R
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004389. PubMed ID: 24163057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rodrigo C; Rajapakse S; Fernando D
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rajapakse S; Rodrigo C; Fernando SD
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
    Graves PM; Choi L; Gelband H; Garner P
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008152. PubMed ID: 29393511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2014 Jun; (6):CD008152. PubMed ID: 24979199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2015 Feb; (2):CD008152. PubMed ID: 25693791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
    Gogtay N; Kannan S; Thatte UM; Olliaro PL; Sinclair D
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008492. PubMed ID: 24163021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mefloquine for preventing malaria during travel to endemic areas.
    Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primaquine for preventing relapses in people with Plasmodium vivax malaria.
    Galappaththy GN; Omari AA; Tharyan P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD004389. PubMed ID: 17253504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
    Pryce J; Hine P
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD006404. PubMed ID: 30620055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.
    Grace AG; Mittal A; Jain S; Tripathy JP; Satyanarayana S; Tharyan P; Kirubakaran R
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012918. PubMed ID: 31828771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.
    Sharma R; Sharma H; Jones S; Borghini-Fuhrer I; Domingo GJ; Gibson RA; Rolfe K; Tan L; Fiţa IG; Chen C; Bird P; Pingle A; Duparc S
    Malar J; 2024 May; 23(1):145. PubMed ID: 38741094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
    Pryce J; Taylor M; Fox T; Hine P
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD006404. PubMed ID: 35726133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
    Sinclair D; Gogtay N; Brand F; Olliaro P
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008492. PubMed ID: 21735431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
    Taylor WRJ; Thriemer K; von Seidlein L; Yuentrakul P; Assawariyathipat T; Assefa A; Auburn S; Chand K; Chau NH; Cheah PY; Dong LT; Dhorda M; Degaga TS; Devine A; Ekawati LL; Fahmi F; Hailu A; Hasanzai MA; Hien TT; Khu H; Ley B; Lubell Y; Marfurt J; Mohammad H; Moore KA; Naddim MN; Pasaribu AP; Pasaribu S; Promnarate C; Rahim AG; Sirithiranont P; Solomon H; Sudoyo H; Sutanto I; Thanh NV; Tuyet-Trinh NT; Waithira N; Woyessa A; Yamin FY; Dondorp A; Simpson JA; Baird JK; White NJ; Day NP; Price RN
    Lancet; 2019 Sep; 394(10202):929-938. PubMed ID: 31327563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens.
    IMPROV Study Group
    BMC Infect Dis; 2015 Dec; 15():558. PubMed ID: 26643116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.